ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
ALR Technologies signed a Letter of Intent to acquire CGM Medical Technology for an aggregate of 200 million ordinary shares and US$45 million, aiming to vertically integrate its diabetes management operations. The deal includes acquiring the Singapore entity for shares and a US$40 million promissory note, plus the Shenzhen assets for up to US$5 million in cash.
Key figures
- Deal Value Usd
- 45000000
- Shares issued
- 200000000
- Cash payment usd
- 5000000
- Promissory note usd
- 40000000
- Equipment purchase usd
- 1650000
- Production target sg monthly
- 500000
- Production target sz monthly
- 300000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.